ASX Runners of the Week: Amplia, archTIS and Vanadium Resources

thewest.com.au - 20/Jun 08:17

This week’s Bulls N’ Bears ASX Runners of the Week is… Amplia Therapeutics. The biotech beauty might just be onto a fabled golden bullet for...

smh.com.au - 20/Jun 08:19

This week’s Bulls N’ Bears ASX Runners of the Week is… Amplia Therapeutics, after the company unveiled results for a potential golden bullet for...

smh.com.au - 20/Jun 08:19

This week’s Bulls N’ Bears ASX Runners of the Week is… Amplia Therapeutics, after the company unveiled results for a potential golden bullet for...

smh.com.au - 27/Jun 07:10

This week’s Bulls N’ Bears ASX Runners of the Week is… Ovanti Ltd, after the company scored a buy now, pay later maestro to guide its US...

thewest.com.au - 27/Jun 07:10

This week’s Bulls N’ Bears ASX Runners of the Week is… Ovanti Ltd, after the company scored a buy now, pay later maestro and former Zip Co exec...

thewest.com.au - 27/Jun 07:10

This week’s Bulls N’ Bears ASX Runners of the Week is… Ovanti Ltd, after the company scored a buy now, pay later maestro and former Zip Co exec...

stockhead.com.au - 19/Jun 00:56

The ASX dipped a tad in morning trade, with the tech and materials sectors lagging. Amplia Therapeutics has reported a ...

stockhead.com.au - 27/Jun 04:24

Clinical stage biotech Prescient Therapeutics is developing new therapies for cancers of unmet need, including cutaneous T-Cell lymphoma (CTCL). ...

stockhead.com.au - 27/Jun 04:24

Clinical stage biotech Prescient Therapeutics is developing new therapies for cancers of unmet need, including cutaneous T-Cell lymphoma (CTCL). ...

pharmabiz.com - 22:49

Tango Therapeutics, Inc., a clinical─stage biotechnology company committed to discovering the next generation of precision cancer medicines,...

Rubriques :